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New roles for renal potassium channels
Abstract
The role of the kidney in controlling and maintaining plasma potassium levels in the normal range
requires the presence and activity of renal potassium channels, and their importance has been
highlighted in patients with Bartter syndrome harboring mutations in the ROMK (Kir1.1, KCJN1)
channel and hyperkalemia. However, the kidney expresses far more potassium channels than ROMK.
Their functions are slowly emerging from studies in animal models and human rare inherited disorders
that allow a better understanding of the plethora of functions that potassium channels fulfill in the
kidney. Three recent studies shed light on the function of 2 members of the family of voltage-gated
potassium channels. The group of René Bindels demonstrates that patients with isolated
hypomagnesemia and inappropriately normal magnesuria carry mutations in the Kv1.1 (KCNA)
potassium channel (Glaudemans B, et al. J Clin Invest. 2009;119:936-942). Two other studies elucidate
a rather complex syndrome involving seizures, ataxia, deafness and renal salt loss, and show that
mutations in the Kir4.1 (KCNJ10) potassium channel are responsible (Scholl UI, et al. Proc Natl Acad
Sci U S A. 2009;106:5842-5847; Bockenhauer D, et al. N Engl J Med. 2009;360:1960-1970). This
human disease is recapitulated by a mouse model deficient for the Kir4.1 channel presenting with
similar symptoms. These studies together show that potassium channels in the kidney serve purposes far
beyond controlling systemic potassium homeostasis, and are involved in various essential functions of
the kidney. Moreover, defects of 2 different potassium channels expressed on opposing membrane
domains of the same cells cause distinct symptoms.
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Abstract 
The role of the kidney in controlling and maintaining plasma potassium levels 
in the normal range requires the presence and activity of renal potassium channels 
and their importance has been highlighted in patients with Bartter’s syndrome 
harboring mutations in the ROMK (Kir1.1, KCJN1) channel and hyperkalemia. 
However, the kidney expresses far more potassium channels than ROMK. Their 
functions are slowly emerging from studies in animal models and human rare 
inherited disorders that allow a better understanding of the plethora of functions that 
potassium channels fulfill in the kidney. Three recent studies shed light on the 
function of two members of the family of voltage-gated potassium channels.  The 
group of René Bindels demonstrates that patients with isolated hypomagnesemia 
and inappropriately normal magnesuria carry mutations in the Kv1.1 (KCNA) 
potassium channel (Glaudemans B, et al.. A missense mutation in the Kv1.1 voltage-
gated potassium channel-encoding gene KCNA1 is linked to human autosomal 
dominant hypomagnesemia. J Clin Invest. 119: 936-42, 2009). Two other studies 
elucidate a rather complex syndrome involving seizures, ataxia, deafness, and renal 
salt loss and show that mutations in the Kir4.1 (KCNJ10) potassium channel are 
responsible (Scholl UI, et al.. Seizures, sensorineural deafness, ataxia, mental 
retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in 
KCNJ10. Proc Natl Acad Sci USA 106: 5842-7, 2009; Bockenhauer D, et al.. 
Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N 
Engl J Med. 360: 1960-70, 2009). This human disease is recapitulated by a mouse 
model deficient for the Kir4.1 channel presenting with similar symptoms. These 
studies together show that potassium channels in the kidney serve purposes far 
beyond controlling systemic potassium homeostasis and are involved in various 
essential functions of the kidney. Moreover, defects of two different potassium 
channels expressed on opposing membrane domains of the same cells cause 
distinct symptoms. 
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Potassium channels are expressed in virtually all cells of the human body and 
fulfill very different functions depending on their cellular environment such as cell 
volume control, membrane potential stabilization and excitability, or regulation of 
hormone or ion secretion (1-4). Distinct families of potassium channels have evolved 
adapted to these specific requirements that differ in their voltage dependence, mode 
of activation, regulation, structure, and ultimately their function. In the kidney, 
potassium channels are found and active in all the different segments of the nephron 
as well as in cells forming the glomerulum, the vasculature, and interstitium. 
Obviously, these potassium channels are not all involved in controlling and 
maintaining plasma potassium homeostasis. For example, potassium channels along 
the proximal tubule may stabilize the membrane potential in order to maintain the 
driving force to reabsorb solutes such a s glucose, amino acids, or bicarbonate (2). In 
the thick ascending limb, luminal potassium channels recycle potassium to drive 
NaCl absorption via the furosemide-sensitive sodium-potassium-chloride 
cotransporter NKCC2. This potassium channel, ROMK (renal outer medullary 
potassium channel) is also found along the collecting duct in principal cells, where 
ROMK mediates potassium secretion into urine to remove potassium from the body 
(5). Other potassium channels such as the BK channels (maxiK channels) are found 
in different parts of the kidney and may be involved in the control of renin secretion 
(1) or the flow-dependent secretion of potassium into urine (6). Thus, potassium 
channels found along the nephron are not necessarily directly involved in renal 
potassium secretion or reabsorption but may rather support other transport functions 
of the nephron segments (5, 7). 
Many inherited and acquired diseases have been identified that are caused by 
mutations or functional alterations in potassium channels such as epilepsy, 
sensorineural deafness, cardiac arrhythmia, diabetes, or renal hyperkalemia. Three 
recent human genetic studies expand the list of examples of such “supportive” 
functions of potassium channels and provide compelling evidence for the distinct and 
sometimes unexpected functions of potassium channels (8-10). 
The group of René Bindels in Nijmegen examined a family with isolated 
autosomal dominant hypomagnesemia with inappropriately normal urinary 
magnesium excretion suggestive of a renal defect in magnesium handling (8). 
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Surprisingly, positional cloning identified the Kv1.1 potassium channel and mutations 
in the patients cosegregated with the disease. Localization of the channels in the 
kidney demonstrated luminal expression in the distal convoluted tubule (DCT) and 
connecting tubule (CNT). These segments express also the TRPM6 magnesium 
channel critical for regulated magnesium reabsorption in the kidney as evident from 
another rare disorder with hypomagnesemia and hypermagnesuria due to mutations 
in the TRPM6 channel (11-13). TRPM6 activity is dependent on the membrane 
potential, being more active at negative membrane potentials, i.e. reabsorbing more 
magnesium. Glaudemans and colleagues show that Kv1.1 may clamp the membrane 
potential to more negative values and thereby enhances TRPM6 mediated 
magnesium reabsorption. The mutation found in the family, on the other hand, 
reduces Kv1.1 channel activity (also in the heterozygote state) and this in turn 
depolarizes the membrane decreasing TRPM6 function (8). Thus, the authors 
propose a model where the membrane potential across the luminal membrane of 
DCT and CNT cells is maintained negative and providing the driving force for 
magnesium reabsorption. Depolarization of the membrane reduces TRPM6 function 
and leads to hypermagnesuria (Figure 1A). 
 
Two other recent publications characterize a complex syndrome consisting of 
a combination of epilepsy/seizures, ataxia, sensorineural deafness, and a renal 
tubulopathy (9, 10). The renal symptoms include hypokalemia, metabolic alkalosis 
and hypomagnesemia with hypocalciuria. These symptoms are very reminiscent of 
patients treated with thiazide diuretics or suffering from Gitelman’s syndrome, a rare 
disorder due to mutations of the thiazide-sensitive NaCl cotransporter affecting the 
function of the distal convoluted tubule. However, the group R. Lifton describes four 
families with a mutation in the Kir4.1 potassium channel (KCJN10) (10). A more 
extensive study was performed by Bockenhauer and colleagues investigating similar 
patients and finding independently also mutations in the Kir4.1 channel in two 
families with a high degree of consanguinity (9). This group went on and 
demonstrated that Kir4.1 is expressed in the kidney with high specificity only in the 
distal convoluted tubule on the basolateral membrane. They further demonstrate that 
all mutations detected in patients render the mutant channels less active or even 
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inactive. A last and very important piece of evidence for the role of Kir4.1 is produced 
by the fact that the same group investigated also a mouse model genetically deficient 
for Kir4.1 and shows that these mice have a similar phenotype consisting of seizures, 
ataxia, hearing loss, and renal loss of sodium with hypocalcuria. In contrast to 
patients, Kir4.1 deficient mice die around 3 weeks after birth possibly due to the 
complete absence of Kir4.1 function. What is the role of Kir4.1 in the distal 
convoluted tubule ? Bockenhauer et al. speculate that Kir4.1 is critical for potassium 
recycling across the basolateral membrane of DCT cells. Potassium is taken up by 
the basolateral Na+/K+-ATPase and must be recycled to maintain sodium/potassium 
pump activity. Loss of Kir4.1 function may then reduce Na+/K+-ATPase function 
accumulating sodium intracellularly and thereby reducing salt absorption across the 
luminal membrane from urine (Figure 1B). The result is a salt-loosing tubulopathy 
similar to mutations in the thiazide-sensitive NaCl cotransporter NCC as found in 
patients with Gitelman’s syndrome. The same symptoms can also be observed in 
patients with chronic thiazide diuretics (14). The renal salt loss causes extracellular 
volume contraction and in turn triggers the compensatory activation of the renin-
angiotensin-aldosterone system (RAAS). This is indeed observed in patients with 
Kir4.1 mutations, elevated levels of renin and aldosterone were found by 
Bockenhauer et al.. Activation of the RAAS increases salt absorption in the proximal 
tubule at the expense of higher bicarbonate reabsorption explaining metabolic 
alkalosis in patients. Similarly, increased calcium absorption may take place in the 
proximal tubule leading to hypocalcuria.  
Thus, both new syndromes describe novel functions of potassium channels in 
the kidney. The existence of basolateral potassium channels in the distal nephron 
had been described functionally for a long time. Moreover, it had been postulated 
that these channels could contain Kir4.1 subunits and that these channels may be 
important for salt reabsorption. However, only the genetic data presented by 
Bockenhauer and Scholl provide now compelling evidence that Kir4.1 channels are 
critical for DCT function and particularly salt absorption by the kidney. In the case of 
the thiazide-sensitive NCC transporter it has been shown that genetic alterations of 
only one allele may confer a mild phenotype, i.e. mild hypotension or protection from 
salt-sensitive hypertension (15, 16). Whether single nucleotide polymorphisms 
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(SNPs), mutations, or altered regulation of Kir41 are associated with blood pressure 
in a more general population remains to be investigated, it is certainly an interesting 
hypothesis to be tested.    
 
Figure legends 
Figure 1 
A) Possible role of the Kv1.1 channel in stabilizing the luminal membrane 
potential of distal convoluted cells (DCT cells). DCT cells express the 
thiazide-sensitive NaCl cotransporter NCC and the luminal TRPM6 
magnesium channel. Absorption of magnesium depolarizes the luminal 
membrane but efflux of potassium through the Kv1.1 channel would 
maintain an inside negative membrane potential providing the driving force 
for further magnesium reabsorption. A reduction or loss of Kv1.1 function 
would lead to a less negative membrane potential across the luminal 
membrane, reduce magnesium reabsorption, and consequently cause 
magnesuria (right panel).  
B) Model of Kir4.1 function on the basolateral membrane of DCT cells. NaCl is 
reabsorbed by the luminal thiazide-sensitive NaCl cotransporter NCC and 
sodium leaves the cell across the basolateral membrane through the action 
of the Na+/K+-ATPase. The potassium taken up must be released again, 
possibly requiring Kir4.1 potassium channels and thereby maintaining a 
negative membrane potential across the basolateral membrane. Impaired 
Kir4.1 function (right panel) reduces Na+/K+-ATPase activity, and ultimately 
inhibits NCC function leading to salt loss similar to thiazide diuretics or 
Gitelman’s syndrome. 
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